Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Investigators at Bristol-Myers Squibb identify novel dAbs targeting CD40-L

July 20, 2012

NVP-BKM120 shows potential in models of follicular lymphoma

July 20, 2012

Novel BACE inhibitor shows promise to treat Alzheimer's disease

July 20, 2012

Scientists in China links gene's expression levels to severity of cognitive impairment

July 20, 2012

New S100-A4-neutralizing antibody is a potential therapy and biomarker for cancer

July 19, 2012

First clinical trials assess TOL-101 for preventing kidney transplant rejection

July 19, 2012

Novel product reduces accumulation of oligomeric beta-amyloid in brain

July 19, 2012

First clinical data disclosed on new beta-secretase 1 inhibitor for Alzheimer's disease

July 19, 2012

U.S. scientists develop new model of early-onset Alzheimer's disease

July 18, 2012

Phase II results presented on insulin analogue for diabetes

July 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...